Skip to content

Catalyst4, Inc., 10% owner at MapLight Therapeutics, bought MPLT on Jul 30, 2026

Data as of Oct 16

▲ BUY$13M1,000,000 shares at $13.00Catalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.
Watch MPLT
Traded
Jul 30, 2026
Disclosed
Jul 30, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Catalyst4, Inc., 10% owner at MapLight Therapeutics, bought MPLT on Jul 30, 2026TRADEDDISCLOSED
MPLTSimilar stocks (XLV — its sector index fund), rebased to MPLT's price on the disclosure day
MPLT since disclosure
−45.1%
Similar stocks (XLV) since disclosure
+8.1%
XLV — its sector index fund

Change in closing price from Jul 30, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$37.9Kdisclosed Jul 30 · filed 1 day after the trade
  2. ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$761Kdisclosed Jul 30 · filed 2 days after the trade
  3. ▲ BUYCatalyst4, Inc. 10% ownerMPLT MapLight Therapeutics, Inc.$1.5Mdisclosed Jul 30 · filed 2 days after the trade

See every trade on MPLT →